The 3 analysts offering 12-month price forecasts for Champions Oncology Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +24.43% increase from the last price of 8.84.
The current consensus among 3 polled investment analysts is to Buy stock in Champions Oncology Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.00
Reporting Date Sep 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.